Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 31-40 of 60
Item hits:
Issue DateTitleAuthor(s)
1-Jan-2021JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortalityStebbing, J; Nievas, GS; Falcone, M; Youhanna, S; Richardson, P, et al
4-Feb-2021What is the intermediate host species of SARS-CoV-2?Friend, T; Stebbing, J;
18-Dec-2020What is the best drug to treat COVID-19? The need for randomized controlled trialsOttaviani, S; Stebbing, J;
17-Mar-2021LMTK3 inhibition affects microtubule stabilityCilibrasi, C; Ditsiou, A; Papakyriakou, A; Mavridis, G; Eravci, M, et al
17-Nov-2020Repurposing fostamatinib to combat SARS-CoV-2-induced acute lung injury.Tabassum, N; Zhang, H; Stebbing, J;
2-May-2020CNS penetration of potential anti-COVID-19 drugs.Richardson, PJ; Ottaviani, S; Prelle, A; Stebbing, J; Casalini, G, et al
20-Jun-2021Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trialStebbing, J; Baranau, Y; Baryash, V; Manikhas, A; Moiseyenko, V, et al
7-Jun-2021Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patientsNteliopoulos, G; Page, K; Hills, A; Howarth, K; Emmett, W, et al
-Immunotherapy-related cystitis: case report and review of the literatureZhu, L; Wang, Z; Stebbing, J; Wang, Z; Peng, L, et al
Nov-2020Sports balls as potential SARS-CoV-2 transmission vectors.Pelisser, M; Thompson, J; Majra, D; Youhanna, S; Stebbing, J, et al